| 25.05 12:15 | *DJ Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio |
| 25.05 12:15 | Press Release: Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio |
| 25.05 12:15 | Press Release: Novartis atrasentan Phase III data -2- |
| 25.05 12:00 | Press Release: Novartispresents latestPhase III Fabhalta(R) (iptacopan) datain C3 glomerulopathy(C3G)showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo |
| 25.05 12:00 | Press Release: Novartispresents latestPhase III -2- |
| 25.05 12:00 | Press Release: Novartispresents latestPhase III -3- |
| 24.05 17:39 | Aktien Schweiz etwas leichter - Verschobene Zinssenkungshoffnungen belasten |
| 16.05 17:41 | Aktien Schweiz von Roche und Swiss Re gestützt |
| 16.05 12:47 | Novartis hält nach erfolgreicher Offerte knapp 80% an Morphosys |
| 16.05 11:34 | *DJ Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash |
| 16.05 11:27 | *DJ Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash |
| 16.05 11:27 | Press Release: Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash |
| 16.05 11:27 | Press Release: Novartis meets all tender offer -2- |
| 15.05 17:43 | Aktien Schweiz von günstigen US-Daten auf Jahreshoch gehievt |
| 15.05 16:00 | Press Release: Novartis highlights pioneering -2- |
| 15.05 16:00 | *DJ Novartis highlights pioneering innovation in CML with data from Scemblix(R) Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA |
| 15.05 16:00 | Press Release: Novartis highlights pioneering innovation in CML with data from Scemblix(R) Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA |
| 10.05 17:47 | Aktien Schweiz setzt Aufwärtskurs fort |
| 10.05 15:53 | FDA erteilt Novartis-Mittel Scemblix erneut Breakthrough-Therapy-Status |
| 08.05 17:48 | Aktien Schweiz setzen Aufwärtskurs fort - Nestle fest |
|
|
